The Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-earnings conference call, without giving any more details.

Source : The Economic Times

Link : https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-to-conduct-trials-in-india-for-potential-covid-19-drug/articleshow/75860443.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst